Vision science is the scientific study of visual perception. Researchers in vision science can be called vision scientists, especially if their research spans some of the science's many disciplines.
Fight for Sight is a nonprofit organization in the United States which funds medical research in vision and ophthalmology. It was formed in 1946 as the National Council to Combat Blindness (NCCB), the first non-profit organization in the United States to fund vision research; 2011 marked its 65th anniversary.
Dr. George Spaeth is an American ophthalmologist specializing in glaucoma at Wills Eye Institute. Spaeth is also affiliated with Thomas Jefferson University Hospital, Graduate Hospital of the University of Pennsylvania, Chestnut Hill Hospital, Bryn Mawr Hospital, and Miner's Memorial Hospital.
Julia A. Haller is an American ophthalmologist who is a Professor and Chair of the Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University. She also holds the William Tasman, M.D. Endowed Chair at Wills Eye Hospital in Philadelphia, where she is Ophthalmologist-in-Chief.
The Federation of European Pharmacological Societies (EPHAR) is a non-profit voluntary association established to advance research and education in the science of pharmacology and to promote co-operation between national/regional pharmacological societies in Europe and surrounding countries. It is an umbrella organization of currently 27 national societies for pharmacology and represents over 10,000 individual pharmacologists in Europe. Moreover it seeks to co-operate with other international organizations, especially the International Union of Basic and Clinical Pharmacology (IUPHAR) of which EPHAR is an associate member.
Martin Jeffrey Steinbach was an American vision researcher who spent most of his career in Canada. He was Distinguished Research Professor Emeritus in the Department of Psychology at York University. He received a master's degree from Connecticut College in 1965 and a Ph.D. from Massachusetts Institute of Technology (MIT) in 1968.
The Association for Ocular Pharmacology and Therapeutics (AOPT) is an organization that welcomes members from disciplines related to ocular pharmacology and its therapeutic applications. The mission of AOPT is the sustenance of a scientific network aiming the dissemination of knowledge in the field of ocular disease, pharmacology and therapeutics.
Reza Dana is the Claes H. Dohlman Professor of Ophthalmology, senior scientist and W. Clement Stone Clinical Research Scholar at Massachusetts Eye and Ear, Harvard Medical School, and director of the Harvard-Vision Clinical Scientist Development Program.
Michael David Abràmoff is a Dutch-American ophthalmologist, computer scientist and entrepreneur. He is the Robert C. Watzke Professor of Ophthalmology and Visual Sciences at the Roy J. and Lucille A. Carver College of Medicine at the University of Iowa. He is the Founder and Executive Chairman of Digital Diagnostics, of Iowa City, called by Wired Magazine "the bolder AI company", and which received the first FDA marketing authorization for an autonomous diagnostic AI system in any field of medicine.
Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.
Maria Pia Abbracchio is an Italian pharmacologist who researches the biochemical effect of drugs at the cellular level. She has conducted research all over the world and is one of the scientists Thomson Reuters has named as most cited scientists since 2006. She is known for her work with purinergic receptors and identification of GPR17. In 2014 she was awarded the Order of Merit of the Italian Republic for her individual scientific accomplishments.
Silvio Garattini is an Italian scientist, pharmacology research scientist, physician and professor in chemotherapy and pharmacology and director of the Mario Negri Institute for Pharmacological Research.
John E. Dowling is an American neuroscientist and Gordon and Llura Gund Research Professor of Neurosciences at Harvard University. He is best known for his seminal work in vision science, having elucidated the biochemistry of rhodopsin and development of the vertebrate retina, as well as diseases that affect vision such as vitamin A deficiency and retinitis pigmentosa. He was elected to the American Academy of Arts and Sciences in 1972, the National Academy of Sciences in 1976, and the American Philosophical Society in 1992.
Patricia Ann D'Amore is a professor at Harvard Medical School, where she is the Charles L. Schepens Professor of Ophthalmology, and Professor of Pathology.
Dimitri Azar M.D. is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Dr. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018.
Steven J. Fliesler is an American biochemist and cell biologist, whose research has focused on how lipid metabolism supports the normal structure and function of the vertebrate retina. He currently is the Meyer H. Riwchun Endowed Chair Professor of Ophthalmology and Vice-Chair/Director of Research in the Department of Ophthalmology, Jacobs School of Medicine and Biomedical Sciences, at the University at Buffalo, The State University of New York. In 2014, he became a UB Distinguished Professor, and in 2018 was promoted to the rank of SUNY Distinguished Professor. He is the author or coauthor of more than 150 publications, including peer-reviewed scientific/biomedical journal articles, books and book chapters.
The Association for Research in Vision and Ophthalmology is an American learned society dedicated to ophthalmology and other vision-related topics. As of 2019, it has almost 12,000 members from 75 different countries. It was established in Washington, D.C., in 1928 as the Association for Research in Ophthalmology. In May 1970, it was renamed to its current name to reflect its broader scope. It is based in Rockville, Maryland. It publishes three academic journals: Investigative Ophthalmology & Visual Science, the Journal of Vision, and Translational Vision Science & Technology.
Gaetano Giorgio Gemmellaro was an Italian geologist, paleontologist and politician.
Alon Harris, MS, PhD, FARVO is an internationally-active clinical scientist, professor of ophthalmology, educator, inventor and researcher in the field of ocular blood flow and its relationship to diseases of the eye. Harris served as the principal or co-principal investigator on more than 60 research grants, published more than 368 peer-reviewed articles, and wrote 22 books and 69 book chapters. As of 2021, he holds two patents. Harris sits on the Board of Directors of The Glaucoma Foundation and is the Vice Chair of International Research and Academic Affairs and Director of the Ophthalmic Vascular Diagnostic and Research Program at Icahn School of Medicine at Mount Sinai.
Alfredo Arrigo Sadun is an American ophthalmologist, academic, author and researcher. He holds the Flora L. Thornton Endowed Chair at Doheny Eye Centers-UCLA and is Vice-Chair of Ophthalmology at UCLA.
